1,095,396 Shares in Axonics Modulation Technologies Inc (AXNX) Purchased by RTW Investments LP

RTW Investments LP bought a new position in Axonics Modulation Technologies Inc (NASDAQ:AXNX) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 1,095,396 shares of the company’s stock, valued at approximately $16,551,000. Axonics Modulation Technologies makes up approximately 1.5% of RTW Investments LP’s portfolio, making the stock its 19th largest holding.

Several other large investors have also recently made changes to their positions in the company. Diag Capital Management LP bought a new position in shares of Axonics Modulation Technologies in the 4th quarter worth approximately $702,000. Perceptive Advisors LLC bought a new position in shares of Axonics Modulation Technologies in the 4th quarter worth approximately $10,935,000. Barclays PLC bought a new position in shares of Axonics Modulation Technologies in the 4th quarter worth approximately $31,000. American International Group Inc. bought a new position in shares of Axonics Modulation Technologies in the 4th quarter worth approximately $69,000. Finally, Geode Capital Management LLC bought a new position in shares of Axonics Modulation Technologies in the 4th quarter worth approximately $1,135,000. 31.93% of the stock is owned by hedge funds and other institutional investors.

AXNX stock traded down $0.16 on Monday, reaching $23.08. 1,953 shares of the company traded hands, compared to its average volume of 93,243. Axonics Modulation Technologies Inc has a one year low of $11.95 and a one year high of $24.93. The company has a quick ratio of 27.46, a current ratio of 28.09 and a debt-to-equity ratio of 0.16. The firm has a market cap of $647.02 million and a PE ratio of -5.01.

Several brokerages have recently issued reports on AXNX. Zacks Investment Research lowered Axonics Modulation Technologies from a “hold” rating to a “sell” rating in a research report on Friday, March 15th. SunTrust Banks increased their target price on Axonics Modulation Technologies to $26.00 and gave the stock a “buy” rating in a research report on Tuesday, March 5th. Morgan Stanley began coverage on Axonics Modulation Technologies in a research report on Monday, November 26th. They set an “overweight” rating and a $21.00 price objective for the company. Wells Fargo & Co began coverage on Axonics Modulation Technologies in a research report on Monday, November 26th. They set an “outperform” rating and a $22.00 price objective for the company. Finally, Bank of America began coverage on Axonics Modulation Technologies in a research report on Monday, November 26th. They set a “buy” rating and a $23.00 price objective for the company. One investment analyst has rated the stock with a sell rating and four have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $21.98.

WARNING: “1,095,396 Shares in Axonics Modulation Technologies Inc (AXNX) Purchased by RTW Investments LP” was first published by Markets Daily and is the sole property of of Markets Daily. If you are reading this piece of content on another site, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.themarketsdaily.com/2019/03/25/1095396-shares-in-axonics-modulation-technologies-inc-axnx-purchased-by-rtw-investments-lp.html.

Axonics Modulation Technologies Profile

Axonics Modulation Technologies, Inc, a medical technology company, focuses on the design, development, and commercialization of sacral neuromodulation solutions (SNM) solutions. The SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention. The company was formerly known as American Restorative Medicine, Inc and changed its name to Axonics Modulation Technologies, Inc in August 2013.

Recommended Story: Bollinger Bands

Want to see what other hedge funds are holding AXNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axonics Modulation Technologies Inc (NASDAQ:AXNX).

Institutional Ownership by Quarter for Axonics Modulation Technologies (NASDAQ:AXNX)

Receive News & Ratings for Axonics Modulation Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axonics Modulation Technologies and related companies with MarketBeat.com's FREE daily email newsletter.